Cited by 1,965Atherosclerosis and Cardiovascular DiseasesCoronary Interventions and DiagnosticsCardiac Imaging and Diagnostics

Pathophysiology of coronary artery disease

Libby, Peter, Theroux, Pierre·2005·Circulation

Abstract

During the past decade, our understanding of the pathophysiology of coronary artery disease (CAD) has undergone a remarkable evolution. We review here how these advances have altered our concepts of and clinical approaches to both the chronic and acute phases of CAD. Previously considered a cholesterol storage disease, we currently view atherosclerosis as an inflammatory disorder. The appreciation of arterial remodeling (compensatory enlargement) has expanded attention beyond stenoses evident by angiography to encompass the biology of nonstenotic plaques. Revascularization effectively relieves ischemia, but we now recognize the need to attend to nonobstructive lesions as well. Aggressive management of modifiable risk factors reduces cardiovascular events and should accompany appropriate revascularization. We now recognize that disruption of plaques that may not produce critical stenoses causes many acute coronary syndromes (ACS). The disrupted plaque represents a “solid-state” stimulus to thrombosis. Alterations in circulating prothrombotic or antifibrinolytic mediators in the “fluid phase” of the blood can also predispose toward ACS. Recent results have established the multiplicity of “high-risk” plaques and the widespread nature of inflammation in patients prone to develop ACS. These findings challenge our traditional view of coronary atherosclerosis as a segmental or localized disease. Thus, treatment of ACS should involve 2 overlapping phases: first, addressing the culprit lesion, and second, aiming at rapid “stabilization” of other plaques that may produce recurrent events. The concept of “interventional cardiology” must expand beyond mechanical revascularization to embrace preventive interventions that forestall future events.

Integrity signals

Registry

Crossref · 10.1161/circulationaha.105.537878

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Inflammation is a key pathogenic mechanism in many infectious, autoimmune, cardiovascular, and psychiatric diseases.

    “However, with increasing recognition that inflammation is a key pathogenic mechanism in many infectious, autoimmune, cardiovascular, and psychiatric diseases (11–13), the adequacy of this explanation has been called into question (14–15).”
  • The profile suggests that long-term stress brings about functional resistance to glucocorticoid signal transduction in monocytes, reducing inhibition of NF-κB and EGR1 and fostering pro-inflammatory dynamics that promote chronic diseases.

    “This profile suggests a scenario in which long-term stress brings about a functional resistance to glucocortioid signal transduction in monocytes, which reduces inhibition of NF-κB and EGR1, and thereby fosters the kind of pro-inflammatory dynamics that ultimately promote chronic diseases, including diabetes, coronary disease, autoimmune disorders, chronic infections, and some cancers (11–13).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Libby, P., & Theroux, P.
Affiliations
  • Brigham and Women's Hospital (US)
  • From the Donald W. Reynolds Cardiovascular Clinical Research Center (P.L.), Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass, and the Department of Medicine (P.T.), Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada.
Venue
Circulation
Published
2005-06-28
Volume
111
Issue
25
Pages
3481-3488
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2122450058
Cited by
1,965
References
4
Citations by year
2026: 75 · 2025: 131 · 2024: 128 · 2023: 103 · 2022: 96 · 2021: 109 · 2020: 70 · 2019: 78 · 2018: 75 · 2017: 86 · 2016: 82 · 2015: 96 · 2014: 95 · 2013: 96 · 2012: 103
FWCI
7.36
Type
journal article
Language
en
Open access
closed
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
  • Circulation
Funders
National Heart, Lung, and Blood Institute (P50HL056985, HL56985, HL-48743, HL-34636, P01HL048743)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
  • Health Sciences › Medicine › Surgery › Coronary Interventions and Diagnostics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
Keywords
coronary artery disease, atherosclerosis, inflammation, arterial remodeling, acute coronary syndrome, plaque rupture, thrombosis, vulnerable plaque, plaque stabilization, revascularization, cardiovascular risk factors, preventive cardiology
MeSH terms
Constriction, Pathologic, Coronary Artery Disease, Coronary Thrombosis, Humans, Inflammation, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review